154 related articles for article (PubMed ID: 16891119)
1. Flavonoids and cinnamic acid esters as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase: a synthesis, QSAR and modelling study.
Sova M; Perdih A; Kotnik M; Kristan K; Rizner TL; Solmajer T; Gobec S
Bioorg Med Chem; 2006 Nov; 14(22):7404-18. PubMed ID: 16891119
[TBL] [Abstract][Full Text] [Related]
2. Cinnamates and cinnamamides inhibit fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Starcević S; Brunskole M; Rizner TL; Gobec S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):239-41. PubMed ID: 16337334
[TBL] [Abstract][Full Text] [Related]
3. Structural basis for inhibition of 17β-hydroxysteroid dehydrogenases by phytoestrogens: The case of fungal 17β-HSDcl.
Cassetta A; Stojan J; Krastanova I; Kristan K; Brunskole Švegelj M; Lamba D; Lanišnik Rižner T
J Steroid Biochem Mol Biol; 2017 Jul; 171():80-93. PubMed ID: 28259640
[TBL] [Abstract][Full Text] [Related]
4. Cinnamic acid esters as potent inhibitors of fungal 17beta-hydroxysteroid dehydrogenase--a model enzyme of the short-chain dehydrogenase/reductase superfamily.
Gobec S; Sova M; Kristan K; Rizner TL
Bioorg Med Chem Lett; 2004 Aug; 14(15):3933-6. PubMed ID: 15225701
[TBL] [Abstract][Full Text] [Related]
5. 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development.
Marchais-Oberwinkler S; Henn C; Möller G; Klein T; Negri M; Oster A; Spadaro A; Werth R; Wetzel M; Xu K; Frotscher M; Hartmann RW; Adamski J
J Steroid Biochem Mol Biol; 2011 May; 125(1-2):66-82. PubMed ID: 21193039
[TBL] [Abstract][Full Text] [Related]
6. The derivation of a potential transition state for the reduction reaction catalysed by 17beta-hydroxysteroid dehydrogenase--an approximate representation of its active site for use in drug design and discovery.
Owen CP; Ahmed S
Biochem Biophys Res Commun; 2004 May; 318(1):131-4. PubMed ID: 15110763
[TBL] [Abstract][Full Text] [Related]
7. E-ring modified steroids as novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Fischer DS; Allan GM; Bubert C; Vicker N; Smith A; Tutill HJ; Purohit A; Wood L; Packham G; Mahon MF; Reed MJ; Potter BV
J Med Chem; 2005 Sep; 48(18):5749-70. PubMed ID: 16134943
[TBL] [Abstract][Full Text] [Related]
8. Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5.
Krazeisen A; Breitling R; Möller G; Adamski J
Mol Cell Endocrinol; 2001 Jan; 171(1-2):151-62. PubMed ID: 11165023
[TBL] [Abstract][Full Text] [Related]
9. Modification of estrone at the 6, 16, and 17 positions: novel potent inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Allan GM; Lawrence HR; Cornet J; Bubert C; Fischer DS; Vicker N; Smith A; Tutill HJ; Purohit A; Day JM; Mahon MF; Reed MJ; Potter BV
J Med Chem; 2006 Feb; 49(4):1325-45. PubMed ID: 16480268
[TBL] [Abstract][Full Text] [Related]
10. Human 17beta-hydroxysteroid dehydrogenase type 5 is inhibited by dietary flavonoids.
Krazeisen A; Breitling R; Möller G; Adamski J
Adv Exp Med Biol; 2002; 505():151-61. PubMed ID: 12083459
[TBL] [Abstract][Full Text] [Related]
11. Probing the origins of 17β-hydroxysteroid dehydrogenase type 1 inhibitory activity via QSAR and molecular docking.
Srungboonmee K; Songtawee N; Monnor T; Prachayasittikul V; Nantasenamat C
Eur J Med Chem; 2015; 96():231-7. PubMed ID: 25884113
[TBL] [Abstract][Full Text] [Related]
12. Pharmacophore modelling of 17beta-HSD1 enzyme based on active inhibitors and enzyme structure.
Karkola S; Alho-Richmond S; Wahala K
Mol Cell Endocrinol; 2009 Mar; 301(1-2):225-8. PubMed ID: 18822344
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biochemical evaluation and rationalisation of the inhibitory activity of a series of 4-hydroxyphenyl ketones as potential inhibitors of 17beta-hydroxysteroid dehydrogenase type 3 (17beta-HSD3).
Lota RK; Dhanani S; Owen CP; Ahmed S
Bioorg Med Chem Lett; 2006 Sep; 16(17):4519-22. PubMed ID: 16797984
[TBL] [Abstract][Full Text] [Related]
14. Flavonoids and cinnamic acid derivatives as inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Brozic P; Kocbek P; Sova M; Kristl J; Martens S; Adamski J; Gobec S; Lanisnik Rizner T
Mol Cell Endocrinol; 2009 Mar; 301(1-2):229-34. PubMed ID: 18835421
[TBL] [Abstract][Full Text] [Related]
15. Cinnamic acids as new inhibitors of 17beta-hydroxysteroid dehydrogenase type 5 (AKR1C3).
Brozic P; Golob B; Gomboc N; Rizner TL; Gobec S
Mol Cell Endocrinol; 2006 Mar; 248(1-2):233-5. PubMed ID: 16337332
[TBL] [Abstract][Full Text] [Related]
16. Inhibitors of 17beta-hydroxysteroid dehydrogenase type 1.
Brozic P; Lanisnik Risner T; Gobec S
Curr Med Chem; 2008; 15(2):137-50. PubMed ID: 18220769
[TBL] [Abstract][Full Text] [Related]
17. Phytoestrogens as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Krajnc K; Konc J; Gobec S; Stojan J; Lanisnik Rizner T
Steroids; 2005 Aug; 70(9):626-35. PubMed ID: 15927220
[TBL] [Abstract][Full Text] [Related]
18. Structural basis of the multispecificity demonstrated by 17beta-hydroxysteroid dehydrogenase types 1 and 5.
Lin SX; Shi R; Qiu W; Azzi A; Zhu DW; Dabbagh HA; Zhou M
Mol Cell Endocrinol; 2006 Mar; 248(1-2):38-46. PubMed ID: 16480815
[TBL] [Abstract][Full Text] [Related]
19. Phytoestrogens as inhibitors of fungal 17beta-hydroxysteroid dehydrogenase.
Kristan K; Krajnc K; Konc J; Gobec S; Stojan J; Rizner TL
Steroids; 2005 Sep; 70(10):694-703. PubMed ID: 15936789
[TBL] [Abstract][Full Text] [Related]
20. Advances in development of inhibitors of 17beta hydroxysteroid dehydrogenases.
Poirier D
Anticancer Agents Med Chem; 2009 Jul; 9(6):642-60. PubMed ID: 19601747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
